You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1394 Novel oncolytic viral immunotherapy VET3-TGI displays enhanced systemic delivery and inhibits TGFb-signaling while augmenting type-1 immune response in the tumor

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1394 Novel oncolytic viral immunotherapy VET3-TGI displays enhanced systemic delivery and inhibits TGFb-signaling while augmenting type-1 immune response in the tumor

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023192016
Dec 20232606
Jan 20243104
Feb 20242402
Mar 20242802
Apr 20243203
May 20243801
Jun 20242203
Jul 202410008
Aug 20241004
Sep 20242201
Oct 20244605
Nov 20249009
Dec 20244803
Jan 20253405
Feb 20251002
Mar 2025005
Apr 2025001
May 2025002
Jun 2025106
Total754088